WBCPI 99.94 -0.01% BHP 42.43 -0.8181% CBA 126.8 -0.6892% RIO 118.99 -1.0478% CSL 292.01 -0.3379% NAB 35.96 -0.6904% WBC 27.15 -0.3304% ANZ 28.65 -1.0021% WBCPL 104.45 0.4327% WES 65.3 -2.3186% MQG 199.27 0.1206% NEM 63.19 -2.3036% GMG 35.18 -1.9509% FMG 21.26 -2.0728% SQ2 94.8 0.0633% WDS 26.97 -1.9985% RMD 27.74 -13.204% TLS 3.62 -1.0929% WOW 33.43 -0.5947% TCL 12.68 1.0359%

Kalkine’s Premium

New Zealand Stock Research Reports at

  • ZERO COST

  • 7 DAY FREE TRIAL

  • EASY UPGRADE TO PREMIUM PRODUCTS

Get Free Report Now !

By submitting your details and clicking on the button below, you agree to Kalkine's Terms of Use and agree to receive marketing offers, including to be contacted by email or phone, as set out in our Privacy Policy.

FREE ACCESS TO PREMIUM NZX STOCK RESEARCH REPORTS (ANY ONE)

Subscribe to 7 day free trial and get access to one of your chosen report

KALIN®

With investment for medium-to-long-term, we cover stocks in diversified sectors that are undervalued and may have the potential for value generation alongside providing shareholder returns in the form of dividends, and or buy backs.

Global Big Money Report

Featuring high-quality mid-cap to blue-chip stocks with medium and long-term investment horizon. The product caters to individuals, including affluent and High-Net-Worth individuals. The stock selection maintains a balance of conservative and aggressive approach while keeping the right blend of diversified and defensive picks.

FEATURES

  • 01

    Access to Insightful Research Reports by Kalkine for 7 day without paying a cent.

  • 02

    In-depth Research backed by Fundamental Checks and Technical Prowess from Industry Experts.

  • 03

    Actionable Insights on Diversified & Trending Sectors Powered by Unique Stock Selection Framework Factoring in Associated Risks.

FREQUENTLY ASKED QUESTIONS

You can continue with the subscription by paying a one-time fee as per Pricing Plan for one year. Else, you can also choose and buy other reports or subscribe to other <a href="https://kalkine.com.au/products">here</a>. No, the 7-day free trial can not be extended.

Kalkine’s main reports get published on a weekly or fortnightly basis depending upon the frequency of the product. Besides, we also provide daily updates on covered stocks for any company-specific events such as results, trading updates, executive changes, M&As, etc., We also cover stocks around potential opportunity areas, trending themes, upcoming IPOs, etc. in our daily reports.

Our reports provides general insights on stocks across market capitalizations covering broad spectrum of industries. We provide exclusive coverage of stocks in our main reports with deep dives on company performance, strategy, outlook, risks, valuations, fundamental drivers, recommendations, and technical analysis covered as general insights for an investor. We also provide investors a flavor on sectors based on trending themes and macroeconomic updates in our sector report, and market events report identifying emerging opportunities.

Our in-house research at Kalkine is the core engine publishing data-driven tech-enabled reports for subscribers. Our disciplined approach, extensive fundamental research, and the technical eye is backed by a team of rich experienced analysts with professional background holding qualified certifications such as Master’s in Business Administration with specialization in Finance and or Chartered Financial Analysts (CFA). Kalkine staff member supervising the drafting and preparation of research reports holds National Certificate in Financial Services (Financial Advice) (Level 5).

As a part of your paid membership to “KALKINE” reports, we provide subscribers the ability to call and speak to our customer support team about any questions you may have about the reports between the hours of 9:00 AM – 6:00 PM Monday to Friday. The information given by “KALKINE” and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. In summary, “KALKINE” is happy to answer calls regarding our published material, however, due to strict compliance requirements, we simply cannot answer questions related to your personal financial circumstances.